Bevacizumab and diabetic vitrectomy

Int Ophthalmol Clin. 2014 Spring;54(2):111-26. doi: 10.1097/IIO.0000000000000013.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Diabetic Retinopathy / therapy*
  • Humans
  • Intravitreal Injections
  • Treatment Outcome
  • Vitrectomy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab